Patents by Inventor Dieter Flockerzi

Dieter Flockerzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7589205
    Abstract: The compounds of formula I in which A, R1, R2 and R3 have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Grant
    Filed: September 5, 2005
    Date of Patent: September 15, 2009
    Assignee: NYCOMED GmbH
    Inventors: Dieter Flockerzi, Ulrich Kautz, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Jens Christoffers, Anna Rosiak
  • Publication number: 20090030029
    Abstract: The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors.
    Type: Application
    Filed: September 23, 2008
    Publication date: January 29, 2009
    Applicant: Altana Pharma AG
    Inventors: Dieter Flockerzi, Rolf-Peter Hummel, Felix Reutter
  • Publication number: 20090005372
    Abstract: The compounds of formula I in which R1 and R2 have the meanings as given in the description are novel effective PDE2 inhibitors.
    Type: Application
    Filed: August 31, 2005
    Publication date: January 1, 2009
    Applicant: Altana Pharma AG
    Inventors: Beate Schmidt, Steffen Weinbrenner, Dieter Flockerzi, Raimund Kuelzer, Hermann Tenor, Hans-Peter Kley
  • Patent number: 7470704
    Abstract: The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: December 30, 2008
    Assignee: Nycomed GmbH
    Inventors: Dieter Flockerzi, Rolf-Peter Hummel, Felix Reutter
  • Publication number: 20080312225
    Abstract: The compounds of formula (I) in which R1, R2 and R3 have the meanings as given in the description are novel effective PDE2 inhibitors.
    Type: Application
    Filed: January 4, 2006
    Publication date: December 18, 2008
    Applicant: NYCOMED GMBH
    Inventors: Beate Schmidt, Steffen Weinbrenner, Dieter Flockerzi, Raimund Kulzer, Hermann Tenor, Hans-Peter Kley
  • Publication number: 20080280907
    Abstract: The compounds of formula (I) in which R1, R2 and R3 have the meanings as given in the description are novel effective PDE2 inhibitors.
    Type: Application
    Filed: January 4, 2006
    Publication date: November 13, 2008
    Applicant: Aaltana Pharma AG
    Inventors: Beate Schmidt, Steffen Weinbrenner, Dieter Flockerzi, Raimund Kulzer, Hermann Tenor, Hans-Peter Kley
  • Publication number: 20080214536
    Abstract: Compounds of a certain formula (I) in which R1, R2, R3, R31, R4, R5, R51, R6 and R7 have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: March 9, 2006
    Publication date: September 4, 2008
    Applicant: NYCOMED Gmbh
    Inventors: Ulrich Kautz, Beate Schmidt, Dieter Flockerzi, Maria Vittoria Chiesa, Armin Hatzelmann, Christof Zitt, Johannes Barsig, Degenhard Marx, Hans-Peter Kley
  • Publication number: 20080167316
    Abstract: Compounds of a certain formula I in which R1, R2, R3, R31, R4, R5, R51 and Har have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: March 1, 2006
    Publication date: July 10, 2008
    Applicant: Altana Pharma AG
    Inventors: Ulrich Kautz, Beate Schmidt, Dieter Flockerzi, Maria Vittoria Chiesa, Armin Hatzelmann, Christof Zitt, Adrea Wohlsen, Degenhard Marx, Hans-Peter Kley
  • Publication number: 20080119505
    Abstract: Compounds of a certain formula (I), in which R1, R2, R3, R31, R4, R5, R51 and Har have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: January 31, 2006
    Publication date: May 22, 2008
    Applicant: ALTANA Pharma AG
    Inventors: Ulrich Kautz, Beate Schmidt, Dieter Flockerzi, Maria Vittoria Chiesa, Armin Hatzelmann, Christof Zitt, Johannes Barsig, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley
  • Publication number: 20080103168
    Abstract: The compounds of formula I in which A, R1, R2 and R3 have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: September 5, 2005
    Publication date: May 1, 2008
    Applicant: Atlana Pharma AG
    Inventors: Dieter Flockerzi, Ulrich Kautz, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Jens Christoffers, Anna Rosiak
  • Publication number: 20070259868
    Abstract: The compounds of formula I in which R1, R2 and R3 have the meanings as given in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: September 5, 2005
    Publication date: November 8, 2007
    Applicant: Altana Pharma AG
    Inventors: Dieter Flockerzi, Ulrich Kautz, Armin Hatzelmann, Christof Zitt, Andrea Wohlsen, Degenhard Marx, Hans-Peter Kley, Jens Christoffers, Anna Rosiak
  • Publication number: 20060167034
    Abstract: The compounds of formula I in which R1, R2, R3, R4, R5, R6 and n have the meanings as indicated in the description, are novel effective PDE3/4 inhibitors.
    Type: Application
    Filed: August 29, 2003
    Publication date: July 27, 2006
    Applicant: Altana Pharma AG
    Inventors: Dieter Flockerzi, Rolf-Peter Hummel, Felix Reutter
  • Publication number: 20060116518
    Abstract: Compounds of a certain formula 1, in which R1, R2, R3, R31, R4, R5, R51, R6 and R7 have the meanings indicated in the description, are novel effective PDE4 inhibitors.
    Type: Application
    Filed: August 13, 2003
    Publication date: June 1, 2006
    Applicant: Altana Pharma AG
    Inventors: Dieter Flockerzi, Beate Schmidt, Steffen Weinbrenner
  • Publication number: 20060113968
    Abstract: The invention relates to a method and device for transmitting and setting the electrical charge and energy of piezoelectric actuators, which are preferably mounted on moving systems, to which an electrically conductive connection is impossible or can only be made with considerable difficulties. An alternating current of a higher frequency with an amplitude, which depends on the phase position and on the amplitude of a countervoltage, is generated by a frequency generator, and this alternating current is transmitted to a moving partial system by means of an inductive transformer. The higher frequency alternating current (i) coming from the secondary winding of the transformer is impressed into the actuator by means of an electronic setting device that is disconnected according to positive and negative semioscillations or to segments of these semioscillations.
    Type: Application
    Filed: August 13, 2003
    Publication date: June 1, 2006
    Applicant: Altana Pharma AG
    Inventor: Dieter Flockerzi
  • Patent number: 6936622
    Abstract: Compounds of the formula (I), in which R1, R2, R3, R4 and R5 have the meanings indicated in the description, are novel effective PDE3/4 Inhibitors.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: August 30, 2005
    Assignee: Altana Pharma AG
    Inventor: Dieter Flockerzi
  • Publication number: 20040097537
    Abstract: Compounds of the formula (I), in which R1, R2, R3, R4 and R5 have the meanings indicated in the description, are novel effective PDE3/4 Inhibitors.
    Type: Application
    Filed: August 8, 2003
    Publication date: May 20, 2004
    Inventor: Dieter Flockerzi
  • Patent number: 6436952
    Abstract: Compounds of the formula I, in which R1, R2, R3 and R4 have the meanings indicated in the description, are novel active bronchial therapeutics.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: August 20, 2002
    Assignee: BYK Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Dieter Flockerzi
  • Patent number: 6384047
    Abstract: Compounds 8,9-diethoxy-2-methyl-6-[4(p-toluenesulfonamide) phenyl]-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridine and 9-ethoxy-8-methoxy-2-methyl-6-[4-(p-toluenesulfonamido)phenyl]-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridine and medicament compositions based thereon are useful for treating airway disorders, high blood pressure disorders and concomitant disorders connected therewith.
    Type: Grant
    Filed: December 3, 1999
    Date of Patent: May 7, 2002
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventors: Dieter Flockerzi, Armin Hatzelmann
  • Patent number: 6306869
    Abstract: N-oxides of formula 1 wherein R1, R2, R3 and R4 have the meanings given in the description, are selective inhibitors of types 3 and 4 of cyclic nucleotide phosphodiesterase (PDE3, PDE4); they are useful on the one hand as bronchial therapeutics but on the other hand especially for the treatment of disorders of inflammatory nature.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: October 23, 2001
    Assignee: Byk Gulden Lomberg Chemische Febrik GmbH
    Inventor: Dieter Flockerzi
  • Patent number: 6143759
    Abstract: Compounds of formula (I) in which R.sup.4 is a phenyl radical substituted by R.sup.5, where R.sup.5 is a tetrazole-5-yl-radical optionally substituted by a radical R.sup.6, are novel efficacious PDE3/4 inhibitiors.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: November 7, 2000
    Assignee: BYK Gulden Lomberg Chemische Fabrik GmbH
    Inventor: Dieter Flockerzi